Register Now for PHA's 2023 Innovation Summit: Decision Makers Connect |
|
The Population Health Alliance (PHA) is holding a distinctive in person event “PHA23 Innovation Summit "Decision Makers Connect” in Washington, D.C. October 25-26 at the Top of the Hill Conference Center. As the only Population Health Improvement professional and trade event, the summit will focus on marketplace needs that improve the consumer journey and health, achieve quality of care targets, reduce costs and advance technologies to improve efficiency and relieve burdens from an already stretched workforce. The intimate environment will allow you to meet directly with senior leadership colleagues that are your existing and future business partners. For a complete agenda, list of speakers, networking events and registration, visit our summit website!
|
|
Featured PHA Innovation Summit Speaker of the Month |
|
Dr. Mandy Cohen, MPH will be a keynote speaker and present, Value-based Care Traversing Medical, Behavioral and Social Care Needs.
Mandy Cohen, MD is Aledade’s Executive Vice President and the Chief Executive Officer of Aledade Care Solutions, the company’s new health services unit. Dr. Cohen was most recently the Secretary of the North Carolina Department of Health and Human Services, where she led the state’s COVID response and transformation of North Carolina’s Medicaid program, focusing on whole-person care and the non-medical drivers of health. Dr. Cohen also served as the Chief Operating Officer and Chief of Staff at the Centers for Medicare and Medicaid Services, helping to implement the Affordable Care Act’s health insurance exchanges and innovative new payment models. Dr. Cohen has been elected to the National Academy of Medicine and is an adjunct professor at the UNC Gillings School of Global Public Health. Dr. Cohen received her MD from Yale University School of Medicine and her Master’s in Public Health from Harvard T.H. Chan School of Public Health. She trained in internal medicine at Massachusetts General Hospital.
|
|
Melissa Fox to Serve as PHA President
PHA is pleased to announce that Melissa Fox, MHA, FACMPE, FACHE will now serve as PHA's President.
“Melissa continues to demonstrate excellence in her approach and passion for the mission of Population Health Alliance, our community of members and improvement in health and access to care for all individuals," said PHA Chairman Emeritus Rose Maljanian, Chairman & CEO HealthCAWS.
Ms. Fox is the Chief Operating Officer at Acenda Integrated Health. Acenda is a nonprofit organization dedicated to industry-leading prevention, treatment, and wellness services compassionately delivered to ensure that every individual, family, and community achieves their greatest potential. Acenda provides health and social service programs across 56+ locations throughout New Jersey.
In her current role as COO, Melissa Fox oversees the operations and systems of more than 100 programs throughout 13 counties in New Jersey. As a family services agency, Acenda provides evidence-based programming in child welfare, prevention, juvenile justice, outpatient mental health, crisis services, substance use disorder treatment, and supportive housing. Under Melissa’s leadership, the Acenda team has received funding to launch innovative programming including a residential program for pregnant women in recovery, an initiative which provides housing and support services for families at risk of homelessness, and a regional partnership grant to provide supports to children who may be at risk due to a caregiver or parent’s substance use disorder.
Melissa has had a distinguished career of 20+ years leading innovations in health care operations including Federally Qualified Health Centers, Healthcare for the Homeless, Behavioral Health, Home Care and Hospice. Fox is a member of the American College of Healthcare Executives, the National Association of Health Services Executives, and the Medical Group Management Association and is an adjunct faculty member for Health Administration at Wilmington University. She has been featured in the South Jersey Journal as a top African American Leader in Healthcare, as well as a 2019 Most Influential African American. She has also been recognized as one of the 2021 African American Women Leaders in New Jersey by the South Jersey Journal.
|
|
PHA Recognizes Board of Directors Members Now on PHA's Alumni Board |
|
The Population Health Alliance Board of Directors recognized six outstanding Board members for their long-term service to the organization having been re-elected for the maximum number of terms allowable by the organization’s bylaws: Dr. Anthony Akosa, Dr. John Brooks, III, Dr. Raymond Fabius, Dr. Mary Jane Osmick, John Robitscher, MPH, and Dr. Sandeep Wadhwa. These individuals were transitioned to the PHA Alumni Board so that their institutional knowledge and strategic and clinical recommendations may continue to strengthen PHA and contribute to the growing population health improvement movement. “On behalf of the entire Board of Directors, I would like to extend our sincerest appreciation and congratulations to these individuals for their unwavering commitment to PHA and their exemplary service to PHA and the industry” said PHA Chairman Emeritus Rose Maljanian, Chairman & CEO HealthCAWS.
|
|
Our Official Journal -Population Health Management
|
|
Population Health Management is the official journal of the Population Health Alliance. PHA corporate members receive a complimentary subscription. We encourage our members to submit articles for peer review to showcase their evidence-based practices and innovations to more than 14,000 corporate and individual subscribers. Population Health Management provides comprehensive, authoritative strategies for improving the systems and policies that affect health care quality, access, and outcomes, ultimately improving the health of an entire population. The Journal delivers essential research on a broad range of topics including the impact of social, cultural, economic, and environmental factors on health care systems and practices.
|
|
Thank You to PHA's Innovation Summit Sponsors |
|
Now is the Time to Make the Most of your Presence at PHA's 2023 Innovation Summit |
|
For information about sponsorship opportunities, please review our
|
|
Take a look at some of the latest happenings from our PHA Members |
|
American College of Lifestyle Medicine and National Board for Health & Wellness Coaching announce collaboration to advance the role of behavior change in health care
The American College of Lifestyle Medicine (ACLM) and the National Board for Health & Wellness Coaching (NBHWC) have announced a strategic collaboration to advance behavior change and health and wellness coaching skills among health care professionals and enhance the role for health and wellness coaches on health care teams. The collaboration will provide an avenue for advancing research, education, and awareness to further uncover the benefits of coaching skills within the lifestyle medicine paradigm. Read full story
|
|
i2i Population Health launched by Franciscan Health to Improve Community Health
i2i Population Health, the leading national population health technology platform serving complex populations, announces the release of Franciscan Healthcare Case Study. After implementing i2i Population Health in January 2022, Franciscan has utilized i2iTracks to improve quality and care management, patient satisfaction, and data analytics.
i2i is excited to share this impactful case study on Franciscan Healthcare’s successes. Eliminating cumbersome manual data extractions and time-consuming quality reports in spreadsheets, Franciscan automated care programs and processes for staff to shift hours of time to quality decision-making that drives community health initiatives. With i2iTracks, quality and care teams leverage actionable data that is seamlessly integrated with the EHR to provide dynamic scorecards, registries, and analytics. Read full story
|
|
3M named as one of the World's Most Ethical Companies by Ethisphere Institute for 10th consecutive year
3M was recently recognized by The Ethisphere Institute for ethics and integrity in business conduct and compliance for the 10th straight year. 3M is one of only nine industrial companies worldwide to be honored this year. "At 3M, we are committed to doing things with unwavering integrity," said Michael Duran, 3M senior vice president and chief ethics and compliance officer. "It is our commitment to unwavering integrity that makes it possible to receive this recognition as one of the World's Most Ethical Companies for the 10th straight year. I am truly proud of all of our employees who work to protect 3M's reputation every Read full story
|
|
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer
Novartis recently announced positive topline results from an interim analysis of NATALEE, a Phase III trial evaluating Kisqali® (ribociclib) plus endocrine therapy (ET) in a broad population of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) early breast cancer (EBC) at risk of recurrence1. The Independent Data Monitoring Committee recommended stopping the trial early as the primary endpoint of invasive disease-free survival (iDFS) has been met. Kisqali plus ET significantly reduced the risk of disease recurrence, compared to standard adjuvant ET alone, with consistent benefit in patients with stage II and stage III EBC regardless of nodal involvement1. Read full story
|
|
Geisinger and Sisters of Saints Cyril and Methodius propose plan for behavioral health facility in Mahoning Township
Geisinger and The Sisters of Saints Cyril and Methodius have entered an agreement that will pave the way for an inpatient behavioral health facility in Mahoning Township. The final land purchase is pending township approval of a property subdivision request, which the Sisters and Geisinger submitted earlier this week.
“This agreement and subsequent project continue our long history of service and ministry to those in need,” said Sister Barbara Sable, SS.C.M., president of the Sisters of Saints Cyril and Methodius. “As we worked to find potential partners for our property, it was important that they shared our mission of community and care to our neighbors. We’re pleased to have found that with this agreement, which will fill a critical need for so many with this facility.” Read full story
|
|
Merck and Eisai Provide Update on Phase 3 Trials of KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) In Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017)
Merck and Eisai today provided updates on two Phase 3 trials, LEAP-003 and LEAP-017 investigating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai. LEAP-003: Merck and Eisai are discontinuing the Phase 3 LEAP-003 trial evaluating KEYTRUDA plus LENVIMA for the first-line treatment of adults with unresectable or metastatic melanoma. Read full story
|
|
Blue Cross Blue Shield Association Collaborates with Cyversity to Offer Cybersecurity Mentorship and Training Opportunities for Next Generation of Diverse Leaders
Blue Cross Blue Shield Association (BCBSA) announced its collaboration with Cyversity, a nonprofit association dedicated to the academic and professional success of minority cybersecurity students and professionals, to create a mentorship and training program designed to sponsor the next generation of diverse security leaders through a combination of education, experience and networking. The program offers Blue Cross and Blue Shield companies and Cyversity members foundational education in governance risk and compliance and a choice to further pursue studies in one of three cybersecurity cohorts: application security, network security, or cloud security. Read full story
|
|
University Hospitals Urology Institute Recognized as an Axonics® Center of Excellence
University Hospitals (UH) Urology Institute in Cleveland has been designated an Axonics Center of Excellence by Axonics Inc. The designation specifically recognizes David Sheyn, MD, for his expertise with Axonics Therapy and sincere commitment to changing the lives of patients suffering from bladder and bowel dysfunction. Dr. Sheyn is the Division Chief of Female Pelvic Medicine for the UH Urology Institute and an Associate Professor of Urology and Reproductive Biology at Case Western Reserve University School of Medicine His specialties include female urinary problems, overactive bladder, urinary retention, and fecal incontinence. Read full story
|
|
OptMyCare Collaborates with Crum & Forster Accident & Health Division by leveraging its Predictive Analytics Platform for Greater Insights, Risk Stratification and Mitigation
OptMyCare is collaborating with Crum & Forster's Accident & Health Division by employing the company's proprietary healthcare predictive and descriptive analytics software as a service (SaaS) platform. OptMyCare's stop loss solutions utilize machine learning to predict emerging risk and associated cost. "OptMyCare's SaaS platform provides Crum & Forster with prompt and reliable, clinically oriented risk management insight," said Gary Nidds, Executive Vice President, Crum & Forster Accident & Health.
Healthcare technology leader, and former CEO & Chairman of HMS and Chair of OptMyCare's Advisory Board, Bill Lucia, commented that collaborations like these are essential for risk-bearing entities to mitigate risk and cost. Read full story
|
|
Thomas Jefferson University and Humana Announce Collaboration to Advance Health Equity
Thomas Jefferson University was awarded an endowment and immediate use gift of $15 million to Thomas Jefferson University by Humana to advance community health and health equity, and to support Jefferson’s population health efforts. Humana is working with community partners nationwide to improve health outcomes for populations that have been disenfranchised and marginalized, in areas like Greater Philadelphia and neighboring regions. Read full story
|
|
Bayer AG via BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson’s disease clinical trial
Bayer AG via BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG, today announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson’s disease clinical Read full story
|
|
Commission for Case Manager Certification commends strength of social workers during National Social Work Month
The Commission for Case Manager Certification applauded social workers in March during National Social Work Month for their contributions to improving health care outcomes and announces a new affiliation to support case managers struggling with increasing levels of burnout, depression, and anxiety among the health care workforce. Clients grappling with complex health care needs in a convoluted system face challenges that may hinder their health outcomes. Read full story
|
|
Digital Diagnostics Sheds Light on AI Tech with LumineticsCore™ Product Rebrand
Digital Diagnostics – a leading AI diagnostics company on a mission to transform global healthcare – has rebranded its flagship product, the AI diagnostic system formerly known as IDx-DR, to LumineticsCore™. The name references the words “illuminate”, which means to supply or brighten with light, and “cybernetics”, which is the science of communications and automatic control systems in both machines and living things. Read full story
|
|
Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions
Mars, Incorporated (“Mars”), and Heska Corporation (NASDAQ: HSKA) (“Heska”) recently announced that they have entered into a definitive agreement under which Mars will acquire Heska, a global provider of advanced veterinary diagnostic and specialty products for $120.00 per share. Upon transaction close, Heska will join Mars Petcare, a purpose-driven global business serving pets and pet owners through products and services within veterinary health and diagnostics, nutrition, innovation, and technology. This acquisition will enable the Science & Diagnostics division of Mars Petcare to expand its diagnostic offerings and broadly promote point-of-care veterinary diagnostics to the global pet healthcare Read full story
|
|
Franciscan Health Adult ICU In Indianapolis Receives Beacon Award For Excellence
Franciscan Health's Adult Intensive Care Unit (AICU) team in Indianapolis has earned the American Association of Critical-Care Nurses (AACN) Silver Beacon Award for Excellence.
This three-year award recognizes the high level of care and quality of work environment of this hospital unit’s staff. Units that achieve the Beacon Award standards also meet criteria consistent with many other national quality awards, including Magnet® Recognition and the Malcolm Baldrige National Quality Award. Read full story
|
|
Independent Health, in partnership with Reddy Bikeshare, kicks off its eighth season of providing affordable access to bikes by announcing an expanded footprint into state parks along the Niagara River. Beginning this spring, Reddy will add 7 new stations at Whirlpool, Devil’s Hole, DeVeaux Woods, and Niagara Falls state parks. Read full story
|
|
Are you a PHA member with news to share?
We'd love to include it in this section!
|
|
A Special Thanks to PHA's Corporate Partners
|
|
|
|
|
|
|
